SCHEMBL28275633

SCHEMBL28275633

CO[C@@H]1O[C@@H](CO)[C@H](O)[C@@H](OCc2ccccc2)[C@@H]1NC(=O)OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 3/20 0.62
▸ SLC6A2 P23975 1/20 0.48
▸ LGALS3 P17931 5/20 0.47
▸ SSTR5 P35346 4/20 0.44
▸ SSTR2 P30874 3/20 0.44
▸ SSTR3 P32745 3/20 0.44
▸ SSTR1 P30872 1/20 0.44
▸ SSTR4 P31391 1/20 0.44
▸ LGALS7; LGALS7B P47929 2/20 0.44
▸ LGALS1 P09382 1/20 0.44
▸ MCHR1 Q99705 2/20 0.43
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ LGALS9 O00182 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10524069 1.00 LGALS8 (0.62) LGALS8SLC6A2LGALS3SSTR5SSTR2
SCHEMBL12501263 0.94 LGALS8 (0.64) LGALS8SLC6A2LGALS3LGALS7; LGALS7BLGALS1
SCHEMBL12501267 0.94 LGALS8 (0.64) LGALS8SLC6A2LGALS3LGALS7; LGALS7BLGALS1
SCHEMBL10524869 0.93 LGALS8 (0.54) LGALS8SLC6A2LGALS3SSTR5SSTR2
SCHEMBL8537938 0.89 LGALS8 (0.61) LGALS8LGALS3CA1CA2CA9
SCHEMBL8537936 0.89 LGALS8 (0.61) LGALS8LGALS3CA1CA2CA9
SCHEMBL9238485 0.89 LGALS8 (0.61) LGALS8LGALS3CA1CA2CA9
SCHEMBL7563759 0.85 LGALS8 (0.51) LGALS8SLC6A2LGALS3LGALS7; LGALS7BLGALS1
SCHEMBL16153929 0.84 SLC6A2 (0.52) LGALS8SLC6A2LGALS3
SCHEMBL15754059 0.84 TACR2 (0.47) LGALS8SLC6A2SSTR5SSTR2SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004352-B Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2022-04-29 — — CN claimed
CN-113004352-A Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-06-22 — — CN claimed
CN-109369738-B Preparation method of fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-03-30 — — CN claimed
CN-113004352-B Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2022-04-29 — — CN disclosed
CN-113004352-B Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2022-04-29 — — CN disclosed
CN-113004352-A Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-06-22 — — CN disclosed
CN-113004352-A Preparation method of fondaparinux sodium and fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-06-22 — — CN disclosed
CN-109369738-B Preparation method of fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-03-30 — — CN disclosed
CN-109369738-B Preparation method of fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2021-03-30 — — CN disclosed
CN-109369738-A Preparation method of fondaparinux sodium monosaccharide intermediate 江苏美迪克化学品有限公司 2019-02-22 — — CN disclosed
Send feedback